Acumen Pharmaceuticals, Inc. (ABOS) Profit Margin
Acumen Pharmaceuticals, Inc. (ABOS) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -152433.33% |
| 2022-12-31 | -99665.12% |
| 2023-12-31 | -1047420.00% |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How ABOS compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| NKTR | Nektar Therapeutics | -297.07% |
| KURA | Kura Oncology Inc. | -412.95% |
| VSTM | Verastem Inc. | -677.59% |
| AGIO | Agios Pharmaceuticals Inc. | -764.01% |
| DMAC | DiaMedica Therapeutics Inc. | -1146.80% |
These are five companies in the same sector as ABOS with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Acumen Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("ABOS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ABOS | $3.18 | +2.91% | 0.32M |
| 3 | ||||
| 4 | ||||
| 5 |